Description
Rifaximin is used to inhibit susceptible Gram-positive and Gram-negative bacteria and to investigate transcriptional inhibition and rifamycin resistance mechanisms. It is incorporated into culture media to apply selective pressure in strains carrying rifamycin resistance determinants or to evaluate mutations affecting bacterial RNA polymerase. Rifaximin is a semisynthetic rifamycin derivative with minimal aqueous solubility and limited diffusion in agar, characteristics that can influence its distribution in solid media systems.
Mechanism: Rifaximin binds to the beta subunit of bacterial DNA-dependent RNA polymerase, blocking the initiation of RNA transcription. By preventing RNA chain elongation at an early stage, it suppresses gene expression and inhibits growth in susceptible bacteria. This transcription-targeting activity makes rifaximin useful for examining rpoB mutations, transcriptional stress responses, and cross-resistance patterns within the rifamycin class.
Key Features and Advantages
-
RNA Polymerase Targeting: Directly inhibits bacterial DNA-dependent RNA polymerase, suppressing transcription.
-
Rifamycin Class Selectivity: Shares a well-characterized mechanism with other rifamycins, supporting comparative resistance analysis.
-
Low Diffusion Characteristics: Limited diffusion in agar can be advantageous in experiments requiring localized antimicrobial exposure.
-
Activity Against Gram-positive and Gram-negative Bacteria: Provides broad experimental utility in selective suppression studies.
-
Tool for rpoB Mutation Studies: Commonly used to investigate mutations associated with rifamycin resistance.
Common Applications and Usage Notes
-
Selection of Rifamycin-Resistant Mutants: Applied in agar-based selection to isolate strains carrying mutations in RNA polymerase.
-
Transcriptional Inhibition Studies: Used to examine global transcriptional shutdown and compensatory gene expression responses.
-
Comparative Rifamycin Analysis: Supports evaluation of cross-resistance among rifamycin derivatives.
-
Antimicrobial Susceptibility Testing: Included in broth or agar based assays for organisms relevant to rifamycin evaluation.
-
Localized Exposure Experiments: Limited diffusion properties may be considered when designing agar-based inhibition studies.
Practical Tips
-
Limited Agar Diffusion: Because rifaximin diffuses poorly in agar, zone sizes in diffusion assays may not directly reflect potency. Broth-based assays may provide more consistent quantitative results.
-
Solubility Considerations: Rifaximin has low aqueous solubility relative to rifamycin sodium salts. Ensure complete dissolution in an appropriate solvent system before incorporating into media.
-
Cross-Resistance Awareness: Mutations in rpoB that confer resistance to other rifamycins may also affect rifaximin susceptibility. Interpret comparative results accordingly.
-
Storage/Handling: Upon receipt, store this product at 4°C.
Product Specifications
Rifaximin
Formula: C43H51N3O11
MW: 785.88 g/mol
PubChem CID: 6436173
